27/11/2019 – AB Science will host a live webcast on masitinib in severe asthma on Monday December 2, 2019 Post navigationPreviousPrevious post:Summary of webcast with Key Opinion Leaders on Indolent Systemic MastocytosisNextNext post:Publication of three AB8939 scientific abstracts in the special ASH Annual Meeting issue of BloodRelated PostsPublication of new results in in the peer-reviewed journal Glia that further support masitinib’s potential mode of action in ALS23 December 2019Publication of three AB8939 scientific abstracts in the special ASH Annual Meeting issue of Blood9 December 2019Summary of webcast with Key Opinion Leaders on Indolent Systemic Mastocytosis25 November 2019Clarification regarding the article in the newspaper Les Echos related to the investigation by the French market authorities22 November 2019Positive top-line Phase 3 results for masitinib in severe asthma7 November 2019AB8939 receives Orphan Drug Designation for Acute Myeloid Leukemia from FDA7 November 2019
Publication of new results in in the peer-reviewed journal Glia that further support masitinib’s potential mode of action in ALS23 December 2019
Publication of three AB8939 scientific abstracts in the special ASH Annual Meeting issue of Blood9 December 2019
Clarification regarding the article in the newspaper Les Echos related to the investigation by the French market authorities22 November 2019